Engineering Controls—BSCs/CAIs

April 2021 : State of Pharmacy Compounding - Vol.18 No. 4 - Page #28
Category: CAIs/CACIs (Compounding Aseptic Isolators & Compounding Aseptic Containment Isolators)

Primary engineering controls (PECs) are fundamental to most compounding operations. Biological safety cabinets (BSCs) are increasingly popular. In fact, BSC adoption rates have reached 84% in facilities with 200+ beds. PECs are also well rated by their users. CAIs/CACIs receive 98% satisfaction ratings and are increasingly likely to be located within the cleanroom. Notably, there was no expansion this year for pharmaceutical manufacturing grade isolators, which feature built-in, automated decontamination systems.


Pharmacy directors rely on a wide array of PECs to support compounding operations: 83% use LAFWs, 74% use BSCs, and 28% take advantage of isolators.


Class II, Type A2 BSCs remain the most commonly used, followed by Class II, Type B2 BSCs.


Nuaire leads the CAI/CACI marketplace, along with The Baker Company and Germfree.


Historically, CAIs and CACIs were most commonly utilized in the segregated compounding area. As more facilities comply with USP <800>, isolators are moving into the cleanroom.


Pharmaceutical manufacturing grade isolators feature a built-in, automated decontamination system, yet this advanced technology has not experienced widespread adoption in hospital pharmacies. Looking ahead, just 4% of facilities are planning to purchase this technology over the next 5 years.

Click here to view a larger version of this Chart


2021 State Of Pharmacy Compounding Slides

Login

Like what you've read? Please log in or create a free account to enjoy more of what www.pppmag.com has to offer.

Current Issue